21.08.2014
- The US Department of Justice has closed without charges its ten-month investigation of British-Swedish AstraZeneca revolving around the blood thinner Brilinta. The probe into what...
02.08.2013
- British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...
